Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10936708 | 0.79 | CYP2D6 (0.32) | AOC3ALDH1A1L3MBTL1 | |
| SCHEMBL17048844 | 0.72 | SIGMAR1 (0.38) | TRPA1TAAR1 | |
| SCHEMBL2404033 | 0.72 | TAAR1 (0.39) | TRPA1AOC3TAAR1ALDH1A1L3MBTL1 | |
| SCHEMBL9237606 | 0.71 | TAAR1 (0.33) | TRPA1TAAR1TSHR | |
| SCHEMBL7771377 | 0.70 | TAAR1 (0.39) | TRPA1AOC3TAAR1ALDH1A1L3MBTL1 | |
| SCHEMBL1463127 | 0.67 | — | — | |
| SCHEMBL2703050 | 0.67 | — | — | |
| SCHEMBL28347105 | 0.67 | — | — | |
| SCHEMBL3210180 | 0.67 | — | — | |
| SCHEMBL8163815 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106232791-A | Cleaning compositions comprising alkoxylated polyalkyleneimines, organomodified silicones and silicone-based diluents | 宝洁公司 | 2016-12-14 | — | — | CN | disclosed |
| US-20110190467-A1 | Biological Polysiloxanes | VISION CRC LIMITED (AU) | 2011-08-04 | — | — | US | disclosed |
| US-20090276042-A1 | Biological Polysiloxanes | VISION CRC LIMITED (AU) | 2009-11-05 | — | — | US | disclosed |
| EP-2021399-A1 | BIOLOGICAL POLYSILOXANES | VISION CRC LIMITED (AU) | 2009-02-11 | — | — | EP | disclosed |
| WO-2007128051-A1 | BIOLOGICAL POLYSILOXANES | VISION CRC LIMITED (AU) | 2007-11-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090276042-A1 | Biological Polysiloxanes | PBK, B2M, CD79B | LMNA 390/4885TDP1 4683/4885TRPA1 2996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.